Signature Estate & Investment Advisors LLC Has $876,000 Stock Holdings in MetLife, Inc. $MET

Signature Estate & Investment Advisors LLC lowered its holdings in shares of MetLife, Inc. (NYSE:METFree Report) by 98.5% in the third quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 10,633 shares of the financial services provider’s stock after selling 697,455 shares during the period. Signature Estate & Investment Advisors LLC’s holdings in MetLife were worth $876,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Blue Trust Inc. boosted its stake in shares of MetLife by 3.6% in the 3rd quarter. Blue Trust Inc. now owns 3,585 shares of the financial services provider’s stock valued at $295,000 after purchasing an additional 125 shares in the last quarter. Daymark Wealth Partners LLC boosted its position in MetLife by 4.2% in the third quarter. Daymark Wealth Partners LLC now owns 3,192 shares of the financial services provider’s stock valued at $263,000 after buying an additional 130 shares in the last quarter. Cornerstone Wealth Group LLC grew its stake in shares of MetLife by 4.9% during the third quarter. Cornerstone Wealth Group LLC now owns 2,790 shares of the financial services provider’s stock worth $230,000 after buying an additional 130 shares during the last quarter. UMB Bank n.a. lifted its stake in shares of MetLife by 1.9% in the 3rd quarter. UMB Bank n.a. now owns 7,040 shares of the financial services provider’s stock valued at $580,000 after acquiring an additional 132 shares during the last quarter. Finally, Legacy Capital Wealth Partners LLC boosted its holdings in shares of MetLife by 3.2% during the 2nd quarter. Legacy Capital Wealth Partners LLC now owns 4,355 shares of the financial services provider’s stock valued at $350,000 after acquiring an additional 137 shares in the last quarter. Institutional investors own 94.99% of the company’s stock.

Analyst Ratings Changes

A number of brokerages have recently commented on MET. Wells Fargo & Company lifted their price target on MetLife from $94.00 to $97.00 and gave the company an “overweight” rating in a research note on Tuesday, January 13th. Keefe, Bruyette & Woods decreased their price target on shares of MetLife from $92.00 to $90.00 and set an “outperform” rating for the company in a research report on Tuesday, November 11th. Morgan Stanley set a $101.00 price target on shares of MetLife and gave the stock an “overweight” rating in a report on Monday, December 15th. Evercore set a $97.00 price objective on MetLife and gave the company an “in-line” rating in a report on Tuesday, January 6th. Finally, Weiss Ratings lowered MetLife from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Thursday. Two analysts have rated the stock with a Strong Buy rating, eight have issued a Buy rating and three have issued a Hold rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $95.64.

View Our Latest Analysis on MetLife

MetLife Trading Down 0.1%

NYSE MET opened at $76.29 on Tuesday. The stock has a market capitalization of $50.27 billion, a P/E ratio of 16.23, a P/E/G ratio of 0.68 and a beta of 0.77. The business has a 50 day simple moving average of $78.90 and a 200 day simple moving average of $78.81. The company has a debt-to-equity ratio of 0.50, a current ratio of 0.20 and a quick ratio of 0.18. MetLife, Inc. has a one year low of $65.21 and a one year high of $87.39.

MetLife (NYSE:METGet Free Report) last announced its quarterly earnings data on Wednesday, February 4th. The financial services provider reported $2.58 EPS for the quarter, topping the consensus estimate of $2.34 by $0.24. The company had revenue of $18.61 billion during the quarter, compared to the consensus estimate of $31.43 billion. MetLife had a net margin of 4.38% and a return on equity of 21.81%. The company’s quarterly revenue was up 27.6% on a year-over-year basis. During the same quarter last year, the firm posted $2.08 EPS. Research analysts expect that MetLife, Inc. will post 9.65 earnings per share for the current year.

MetLife Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, March 10th. Shareholders of record on Tuesday, February 3rd will be paid a $0.5675 dividend. This represents a $2.27 annualized dividend and a yield of 3.0%. The ex-dividend date of this dividend is Tuesday, February 3rd. MetLife’s payout ratio is 48.30%.

About MetLife

(Free Report)

MetLife, Inc is a global provider of insurance, annuities and employee benefit programs. Headquartered in New York City, the company offers a range of risk protection and retirement solutions to individuals, employers and institutional clients. Its core businesses include life insurance, group benefits, retirement products such as annuities, and supplemental health products including dental and disability coverage.

In addition to traditional life and group insurance, MetLife provides workplace benefits and voluntary products distributed through employer-sponsored programs.

See Also

Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:METFree Report).

Institutional Ownership by Quarter for MetLife (NYSE:MET)

Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.